Advancing neuroblastoma care: future horizons after approval of eflornithine by FDA. [PDF]
Nazir A, Nazir A, Kandel K.
europepmc +1 more source
Melarsoprol-Free Drug Combinations for Second-Stage Gambian Sleeping Sickness: The Way to Go [PDF]
Chappuis, François
core
Iwilfin (eflornithine) approved by the FDA as the first and only oral maintenance therapy for high-risk neuroblastoma in adult and pediatric patients: Narrative review. [PDF]
Shakeel A +12 more
europepmc +1 more source
Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US. [PDF]
Reggiardo G +7 more
europepmc +1 more source
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer. [PDF]
Kumar R +26 more
europepmc +1 more source
<i>N</i>-Myristoyltransferase Inhibition in Parasitic Pathogens: Insights from Computer-Aided Drug Design. [PDF]
Campos FFGR +8 more
europepmc +1 more source
Synthesis and Combination Studies of Novel Dipeptide Nitriles with Curcumin for a Potent Synergistic Action Against Rhodesain, Cysteine Protease of <i>Trypanosoma brucei rhodesiense</i>. [PDF]
Di Chio C +8 more
europepmc +1 more source
Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas. [PDF]
Kishk A +3 more
europepmc +1 more source
Interventions for Neglected Diseases Caused by Kinetoplastid Parasites: A One Health Approach to Drug Discovery, Development, and Deployment. [PDF]
Ebiloma GU, Alhejeli A, de Koning HP.
europepmc +1 more source

